These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22619307)

  • 1. MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.
    Jarboe JS; Anderson JC; Duarte CW; Mehta T; Nowsheen S; Hicks PH; Whitley AC; Rohrbach TD; McCubrey RO; Chiu S; Burleson TM; Bonner JA; Gillespie GY; Yang ES; Willey CD
    Clin Cancer Res; 2012 Jun; 18(11):3030-41. PubMed ID: 22619307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.
    Eustace NJ; Anderson JC; Langford CP; Trummell HQ; Hicks PH; Jarboe JS; Mobley JA; Hjelmeland AB; Hackney JR; Pedersen RT; Cosby K; Gillespie GY; Bonner JA; Willey CD
    Int J Oncol; 2019 Jun; 54(6):2039-2053. PubMed ID: 30942445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
    Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
    Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
    Park JW; Wollmann G; Urbiola C; Fogli B; Florio T; Geley S; Klimaschewski L
    Neuro Oncol; 2018 Jul; 20(8):1044-1054. PubMed ID: 29635363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic significance of TCTN1 in human glioblastoma.
    Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
    J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma.
    You WC; Chiou SH; Huang CY; Chiang SF; Yang CL; Sudhakar JN; Lin TY; Chiang IP; Shen CC; Cheng WY; Lin JC; Shieh SH; Chow KC
    Neuro Oncol; 2013 Oct; 15(10):1342-52. PubMed ID: 24057885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer.
    Quan R; Ning Z; Wang Y; Yu W; Zhu H
    Med Sci Monit; 2019 Jan; 25():279-287. PubMed ID: 30623893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myristoylated alanine rich protein kinase C substrate is a potential cancer prognostic factor that regulates cell migration and invasion in glioblastoma.
    Xiang W; Peng T; Ming Y; Li S; Wang K; Wang H; Chen L; Zhou J
    Oncol Rep; 2019 Apr; 41(4):2464-2470. PubMed ID: 30816497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.
    Walsh AM; Kapoor GS; Buonato JM; Mathew LK; Bi Y; Davuluri RV; Martinez-Lage M; Simon MC; O'Rourke DM; Lazzara MJ
    Mol Cancer Res; 2015 Aug; 13(8):1227-37. PubMed ID: 25934697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity.
    Rohrbach TD; Jarboe JS; Anderson JC; Trummell HQ; Hicks PH; Weaver AN; Yang ES; Oster RA; Deshane JS; Steele C; Siegal GP; Bonner JA; Willey CD
    Int J Oncol; 2015 Mar; 46(3):1079-88. PubMed ID: 25524703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
    Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.
    Aguila B; Morris AB; Spina R; Bar E; Schraner J; Vinkler R; Sohn JW; Welford SM
    Cancer Lett; 2019 Oct; 462():33-42. PubMed ID: 31377205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma.
    Eustace NJ; Anderson JC; Warram JM; Widden HN; Pedersen RT; Alrefai H; Patel Z; Hicks PH; Placzek WJ; Gillespie GY; Hjelmeland AB; Willey CD
    Oncogene; 2020 Nov; 39(46):6961-6974. PubMed ID: 33077834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival.
    Bickeböller M; Tagscherer KE; Kloor M; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Toth C; Schirmacher P; Roth W; Bläker H
    Oncogene; 2015 Feb; 34(9):1150-9. PubMed ID: 24662837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effector Domain of MARCKS Is a Nuclear Localization Signal that Regulates Cellular PIP2 Levels and Nuclear PIP2 Localization.
    Rohrbach TD; Shah N; Jackson WP; Feeney EV; Scanlon S; Gish R; Khodadadi R; Hyde SO; Hicks PH; Anderson JC; Jarboe JS; Willey CD
    PLoS One; 2015; 10(10):e0140870. PubMed ID: 26470026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
    Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
    Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.
    Meng D; Chen Y; Yun D; Zhao Y; Wang J; Xu T; Li X; Wang Y; Yuan L; Sun R; Song X; Huai C; Hu L; Yang S; Min T; Chen J; Chen H; Lu D
    Oncotarget; 2015 Mar; 6(7):4901-19. PubMed ID: 25669971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.